With a current market value of S$20 billion and an expected compound annual growth rate (CAGR) of 16.4% by 2019, the global wearables industry is a bright spot within the tech world.
Although large global brands such as Apple, Garmin and Samsung dominate wearable technology, there is still a vast and untapped potential beyond fitness and lifestyle applications.
In Singapore, researchers are already developing wearables that have other applications, such as for healthcare, brain training and social adventure photography. The 360-degree cameras on your wrist and a headband that knows when you are tired may soon be a reality, thanks to inventive researchers in Singapore.
Intravenous (IV) drips are routinely attached to hospital patients to administer necessary medications and fluids.
When IV needles leak their contents into the surrounding tissues, they can cause serious injuries such as skin blisters, tissue deaths, limb deformity and limb impairment. This condition is known as extravasation.
Newborns and young children are at a higher risk of extravasation as their veins are smaller and signs of extravasation, such as swelling, are harder to detect in them.
There are currently no effective medical devices in the market to detect extravasations, especially for ‘slow drips’ that deliver less than 50ml of fluids per hour.
To solve this problem, researchers from A*STAR’s Institute of Microelectronics (IME) have developed an adhesive sensor patch that detects ‘micro-swelling’ on the surface of the skin near an IV needle.
Thin and portable, the patch can detect the leakage of as little as 2ml of fluid. The patch sends a signal to a receiver, which then relays the message to the patient’s clinician via a mobile application in real time, allowing for immediate medical intervention.
The patch has been successfully tested in lab experiments and will undergo more comprehensive clinical trials soon. It is expected to enter the market within the next 2 years.
Hands-free cameras are in high demand by sports and adventure enthusiasts who want to capture all the action.
However, some head-mounted cameras have a limited field of view. Local optics start-up, Spacemap, may have the solution.
Spacemap enlisted the help of Randy Hipona, an A*STAR IME research engineer who was seconded under A*STAR’s T-Up programme. Hipona worked on the camera’s electronic parts and the baseline hardware before putting the two together.
The result of their collaboration is Beoncam, an “always on” wrist camera which can take 360-degree panoramic shots.
The camera itself has a 190-degree hemispheric field of view. However, two Beoncam units can be used simultaneously, while its companion smartphone app stitches together these separate shots.
Beoncam, equipped with a 5MP waterproof sensor, Bluetooth and Wi-Fi – is capable of storing 5,000 photos or 4 hours of video footage. It also lasts up to 5 days on a single charge.
Beoncam was well-received when it debuted at the CES 2017 trade show in Las Vegas in January. A month later, Spacemap launched a fundraising campaign on crowdfunding platform indiegogo, where the Beoncam hit twice its original US$30,000 funding target within two months. It currently retails for US$199 and will be available on Singaporean shores by the end of 2017.
As the most complex organ in the human body, the brain plays a significant impact on our daily activities.
However, we may not be aware of the various states of our brain – such as a declining attention span or hormonal-based mood swings – until they reach critical levels.
To enable us to understand our brain health better, researchers at A*STAR’s Institute of Infocomm Research (I2R) have developed a wireless headband that measures neurophysiological signals.
Known as a Wearable Neural Sensing Platform (IWENS), the headband is fitted with high-performance neural sensing technology that can be programmed to detect and measure brain states such as attention, emotions, fatigue and anxiety.
The headband makes use of integrated high-performance electroencephalography (EEG) and photoplethysmography (PPG) sensing to measure, monitor and improve specific brain functions.
Gap-funded by A*STAR’s commercialisation arm ETPL, IWENS has the ability to measure, monitor and improve specific brain functions, which makes it potentially applicable in the areas of attention training, wellness tracking, personal safety and security, as well as entertainment and gaming.
For instance, the headband can be programmed to measure fatigue levels in drivers, and release scents when it detects that the driver is tired to alert them.
Currently a working prototype, IWENS is available for commercialization and licensing by interested parties.
These Singapore-made wearable tech inventions point to an exciting future. Soon, powerful computing can literally be in your hand and help improve our well-being beyond calorie-counting.
To find out how you can license our technologies or partner with A*STAR, email us at email@example.com
Check out the 12th episode of the A*STAR TV Series.
Two days after the World Health Organization (WHO) declared Zika as a public health emergency, A*STAR researchers got into the action.
The Technology Centre for Offshore and Marine Singapore (TCOMS) is Singapore’s first research and development (R&D) centre for the industry.
Singapore's space and satellite sector is one of the new industry clusters groomed for future growth. Find out how A*STAR's T-up scheme helped Addvalue Technologies transition from consumer to leading edge satellite communications.
Noise and heat pollution are inevitable in urban areas. A team of A*STAR researchers are developing ‘green’ building solutions for walls and windows so that city-dwellers can soon enjoy quieter, cooler homes and offices.
With the dawn of digitisation in Singapore’s manufacturing industry, McKinsey & Company partnered with A*STAR’s Advanced Remanufacturing and Technology Centre (ARTC) to develop ‘Project Lighthouse’, a digital capacity platform where companies can test-bed Industry 4.0 solutions.
A*STAR is taking its partnership with British aero-engine giant Rolls-Royce to a deeper level.
NovogeneAIT and Genome Institute of Singapore say centre will devote its sequencing capabilities to support public research projects and empower super scale sequencing initiatives
A*STAR supports Singapore’s vision to be a leading aerospace hub in Asia-Pacific through its Aerospace Programme.
Sometimes, being too comfortable is a risk. Because you don’t realise what is at stake, and you think that it’s someone else’s money.
Singapore faces several challenges, such as uncertain global economic conditions, the rise of regional competition, and an ageing workforce.
Manufacturing is a core industry in Singapore, contributing 20 per cent of the country’s gross domestic product (GDP).
Even though the human genome was sequenced in 2000, much remains to be known about how it encodes our development, physiology, and disease dynamics.
A*STAR announced an enhanced Headstart programme, where local SMEs can enjoy royalty-free and exclusive licences up to 36 months for industry solutions co-developed with A*STAR.
Government investment into pharmaceutical research is thus crucial, together with increasing public-private partnerships to commercialise and market new drugs.
Drug testing is important to help companies develop drugs more accurately, save time and reduce the risk of investing in something that may not eventually work.
Speakers from both public and private sectors spoke at the recent A*STAR-SPRING SME Day 2017 on how strategic partnerships can help pave the way for SMEs to adopt as well as develop technology.
For many years, healthcare field practitioners have been trying to search for a New compound kills bacteria in seconds.
At 398 robots for every 10,000 employees, Singapore has the second highest robot density in the world.
Erratic power supply has often caused Asia’s economic growth to hit speed bumps. Find out how A*STAR, through Institute for Infocomm Research (I2R) and Experimental Power Grid Center (EPGC) .
The company 3D Metalforge also signed a new agreement with SIMTech to commercialise large-format Laser Aided Additive Maanufacturing (LAAM) for industrial 3D printing.
HDB, Imperial College London and A*STAR's Institute for Infocomm Research collaborate on a $5.3 million research programme to study how smart sensing and analytics can enhance housing estates services
At the recent Leaders in Science Forum – organised as part of the one-north Festival, a four-day celebration of research, innovation, creativity and enterprise – industry leaders shared what might be driving this phenomenon and what more can be done to tackle it.
Smaller manufacturing players who want to try the latest hardware without breaking the bank can take advantage of a new sharing scheme set up by the Agency for Science, Technology and Research (A*Star).
A new scheme unveiled yesterday is primed to give drug-makers and the wider manufacturing sector a shot in the arm as disruptive change roils industries and poses huge challenges to bosses.
British engineering giant Rolls- Royce, the Agency for Science, Technology and Research (A*Star) and Singapore Aero Engine Services (SAESL) are investing up to $60 million to set up a facility to develop new technologies for the aerospace industry.
Where manufacturers can test ideas that can raise their competitiveness
Ten years on, the veteran entrepreneur is giving back. He is mentoring and creating startups for the venture co-creation (VCC) initiative together with ETPL.
Pharmaceutical and food ingredient maker to expand staff, team up with A*Star institutes
This year's winners have made a difference in fields as diverse as cancer detection, health and construction. Here's how their T-Up projects contributed to their companies.
A roadmap to transform Singapore's precision engineering industry and to build more smart factories.
TELCO Singtel and Nanyang Technological University (NTU) have set up a S$42.4 million laboratory to develop and commercialise digital technologies.
Aim to improve care, from risk prediction to managing disease
Advent Access to commercialise device easing access to veins, reducing complications from long-term treatment
Osteopore International, a Singaporean medical technology firm, uses 3D printing to restore the human skeleton and heal wounds.
Thirty-six per cent of those polled in the latest survey said that they are satisfied with the current business climate in Singapore - up from 20 per cent a year earlier.